Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus pregabalin for attenuation of hemodynamic responses during laryngoscopy and intubation
IRCT20250701066312N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Gabapentin, Pregabalin and Placebo (3 arms). Primary endpoints: Systolic blood pressure change during laryngoscopy and intubation, Diastolic blood pressure change during laryngoscopy and intubation and 3 more. Started Jul 2025; status: completed.
02
Drugs
gabapentinpregabalin
Beyond the preview
Go deeper on IRCT20250701066312N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250701066312N1.